These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 996056
41. The role of dopamine and noradrenaline in temperature control of normal and reserpine-pretreated mice. Cox B, Tha SJ. J Pharm Pharmacol; 1975 Apr; 27(4):242-7. PubMed ID: 239116 [Abstract] [Full Text] [Related]
45. Inhibition and facilitation of self-stimulation behavior by aversive stimulation. Beyra M, Spinewine P. Physiol Behav; 1973 Mar; 10(3):563-6. PubMed ID: 4708521 [No Abstract] [Full Text] [Related]
46. Age-related decline in brain stimulation reward: rejuvenation by amphetamine. Lewis MJ. Exp Aging Res; 1981 Mar; 7(3):225-34. PubMed ID: 7318851 [Abstract] [Full Text] [Related]
47. Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices. Uretsky NJ, Snodgrass SR. J Pharmacol Exp Ther; 1977 Sep; 202(3):565-80. PubMed ID: 197227 [No Abstract] [Full Text] [Related]
48. Dopaminergic stimulation increases selfish behavior in the absence of punishment threat. Pedroni A, Eisenegger C, Hartmann MN, Fischbacher U, Knoch D. Psychopharmacology (Berl); 2014 Jan; 231(1):135-41. PubMed ID: 23900641 [Abstract] [Full Text] [Related]
49. The role of catecholamines in the action of drugs affecting behavior. Seiden LS. Pharmacol Ther B; 1976 Jan; 2(1):155-65. PubMed ID: 772717 [No Abstract] [Full Text] [Related]
52. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors. Cox B, Kastin AJ, Schnieden H. Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332 [Abstract] [Full Text] [Related]
54. On the brain monoaminergic systems relating to ejaculation. III) Further study by using a peripheral decarboxylase inhibitor. Kimura Y, Miyamoto A, Tadano T, Harada T, Kisara K. Andrologia; 1980 Mar; 12(4):354-9. PubMed ID: 7191642 [Abstract] [Full Text] [Related]
56. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar. Huang L, Deng M, Zhang S, Fang Y, Li L. Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244 [Abstract] [Full Text] [Related]
57. The pharmacology of Parkinson's disease: basic aspects and recent advances. Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE. Experientia; 1984 Nov 15; 40(11):1165-72. PubMed ID: 6437857 [Abstract] [Full Text] [Related]
58. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation. Gallistel CR, Freyd G. Pharmacol Biochem Behav; 1987 Apr 15; 26(4):731-41. PubMed ID: 3602032 [Abstract] [Full Text] [Related]
59. [The phenomenon of experimental motor retardation as one of the manifestations of the Parkinsonian syndrome]. Arushanian EB. Zh Nevropatol Psikhiatr Im S S Korsakova; 1975 Apr 15; 75(4):518-22. PubMed ID: 1210962 [Abstract] [Full Text] [Related]
60. [Effect of catecholamines on the motivational and reinforcing effects of self stimulation zones]. Mikhaĭlova NG, Staikova RM, Cheresharov LP. Zh Vyssh Nerv Deiat Im I P Pavlova; 1979 Apr 15; 29(4):815-22. PubMed ID: 484039 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]